Evidence map›Paper›PMID 34361040›Full record

ArticleInternational journal of molecular sciences2021

The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.

Karolina E Kolaczynska, Jan Thomann, Marius C Hoener, Matthias E Liechti

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Structure-Activity Relationship ofACS chemical neuroscience · 2023
    Article
  14. Review
  15. Article
  16. Molecular Insights on New Psychoactive Substances (NPSs).International journal of molecular sciences · 2022
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Karolina E KolaczynskaDivision of Psychopharmacology Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Jan ThomannDivision of Psychopharmacology Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.
Marius C HoenerNeuroscience Research, pRED, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
Matthias E LiechtiDivision of Psychopharmacology Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.ORCID 0000-0002-1765-9659
University of Basel · CHRoche (Switzerland) · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 16.921318
6 · The paper itself

Abstract

Pyrovalerone cathinones are potent psychoactive substances that possess a pyrrolidine moiety. Pyrovalerone-type novel psychoactive substances (NPS) are continuously detected but their pharmacology and toxicology are largely unknown. We assessed several pyrovalerone and related cathinone derivatives at the human norepinephrine (NET), dopamine (DAT), and serotonin (SERT) uptake transporters using HEK293 cells overexpressing each respective transporter. We examined the transporter-mediated monoamine efflux in preloaded cells. The receptor binding and activation potency was also assessed at the 5-HT

Indexed as

AlkaloidsBiogenic MonoaminesDopamine Plasma Membrane Transport ProteinsHEK293 CellsHumansNorepinephrine Plasma Membrane Transport ProteinsProtein BindingPsychotropic DrugsPyrrolidinesQuantitative Structure-Activity RelationshipSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsAlkaloidsBiogenic MonoaminescathinoneDopamine Plasma Membrane Transport ProteinsNorepinephrine Plasma Membrane Transport ProteinsPsychotropic DrugspyrovaleronePyrrolidinesSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport Proteinscathinoneinhibitionmonoaminenovel psychoactive substancepyrovaleronereceptortransporter

Identifiers

PMID34361040
PMCPMC8348686
OpenAlexW3192052262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.